The 2019 World Health Organization classification of tumours of the breast

Affiliations

¹ Singapore General Hospital, Singapore, Singapore.
² University of Nottingham and Nottingham University Hospitals, Nottingham, UK.
³ Stanford University School of Medicine, Stanford, CA, USA.
⁴ Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁵ Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia.
⁶ University of Queensland and Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, Australia.
⁷ University of Texas MD Anderson Cancer, Houston, TX, USA.
⁸ GZA-ZNA Hospitals, Antwerp, Belgium.
⁹ Department of Medical Sciences, University of Torino, Torino, Italy.
¹⁰ Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.
¹¹ Tohoku University School of Medicine, Sendai, Japan.
¹² Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA.
¹³ Institut Jules Bordet (Université Libre de Bruxelles), Brussels, Belgium.
¹⁴ University Medical Centre Utrecht, Utrecht, The Netherlands.
¹⁵ International Agency for Research on Cancer, Lyon, France.

Puay Hoon Tan et al. Histopathology. 2020 Aug.

. 2020 Aug;77(2):181-185.

doi: 10.1111/his.14091. Epub 2020 Jul 29.

¹ Singapore General Hospital, Singapore, Singapore.
² University of Nottingham and Nottingham University Hospitals, Nottingham, UK.
³ Stanford University School of Medicine, Stanford, CA, USA.
⁴ Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁵ Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia.
⁶ University of Queensland and Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, Australia.
⁷ University of Texas MD Anderson Cancer, Houston, TX, USA.
⁸ GZA-ZNA Hospitals, Antwerp, Belgium.
⁹ Department of Medical Sciences, University of Torino, Torino, Italy.
¹⁰ Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.
¹¹ Tohoku University School of Medicine, Sendai, Japan.
¹² Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA.
¹³ Institut Jules Bordet (Université Libre de Bruxelles), Brussels, Belgium.
¹⁴ University Medical Centre Utrecht, Utrecht, The Netherlands.
¹⁵ International Agency for Research on Cancer, Lyon, France.

No abstract available

References

1. Lakhani SR, Ellis IO, Schnitt SJ et al. eds. World Health Organization classification of tumours of the breast. 4th ed. Lyon: IARC Press, 2012.
1. Rindi G, Klimstra DS, Abedi-Ardekani B et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod. Pathol. 2018; 31; 1770-1786.
1. Tan PH, Schnitt SJ, van de Vijver MJ et al. Papillary and neuroendocrine breast lesions: the WHO stance. Histopathology 2015; 66; 761-770.
1. Lozada JR, Basili T, Pareja F et al. Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort. Histopathology 2018; 73; 339-344.